DOROTHY CHENG: Open Payments
NPI 1588905277 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,644 in 282 payments from 19 companies in 2025. Trend: 2023 $1,722 · 2024 $2,907 · 2025 $5,644
Food & beverage: $4,399Consulting: $1,245
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 39 | $1,957 |
| PFIZER INC. | 49 | $702 |
| ABBVIE INC. | 30 | $530 |
| Celltrion USA Inc. | 28 | $466 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 36 | $424 |
| Aimmune Therapeutics, Inc. | 37 | $354 |
| Phathom Pharmaceuticals, Inc. | 18 | $242 |
| Ipsen Biopharmaceuticals, Inc | 8 | $187 |
| GENZYME CORPORATION | 7 | $173 |
| Ardelyx, Inc. | 7 | $129 |
Products named: TREMFYA, VELSIPITY, VEGZELMA, XIFAXAN, ZENPEP, DUPIXENT, MAVYRET, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
